β-defensin 130 Counteracts ETEC-K88 Infection in Mice: Mechanistic Insights from Gut Microbiome and LC-MS-Based Metabolomic Correlation Analysis
Current Microbiology · 2026
DOI: 10.1007/s00284-026-05189-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2026. Verfasst von Zhiwei Su und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological and Pharmaceutical Engineering, Shandong University of Aeronautics, Binzhou, 256600, Shandong, China. Hauptthemen laut MEDLINE: beta-Defensins, Enterotoxigenic Escherichia coli, Escherichia coli Infections, Gastrointestinal Microbiome. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Binzhou Municipal Medical and Health Science and Technology Project, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
β-defensin 130 is a potential antimicrobial peptide candidate against enterotoxigenic Escherichia coli (ETEC)-K88 infection, but its in vivo mechanism remains unclear. In this study, the antibacterial activity of β-defensin 130 against ETEC-K88 was first evaluated in vitro, and membrane damage was observed by morphological disruption and PI uptake. Then, an ETEC-K88-infected mouse model was established and treated with β-defensin 130. Based on 16 S rDNA sequencing and LC-MS metabolomics, ETEC-K88 infection was shown to reduce gut microbial diversity and alter community structure. Correlation analysis revealed significant microbiota-metabolite interactions, β-defensin 130 treatment was associated with increased gut microbial diversity and partial recovery of the gut microbial community, increased beneficial Bacteroidota / Firmicutes , decreased pathogenic Proteobacteria , and partial reversal of infection-associated metabolic disturbances (e.g., upregulating L-tryptophan and linoleic acid). Collectively, these findings suggest that β-defensin 130 may alleviate ETEC-K88 infection by disrupting bacterial membranes, modulating gut microbiota, and partially restoring metabolic homeostasis, supporting its further development as a potential antimicrobial agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Biological and Pharmaceutical Engineering, Shandong University of Aeronautics, Binzhou, 256600, Shandong, China.
- Institute of Oceanology, Chinese Academy of Sciences, Qingdao, 266071, China.
- Binzhou People's Hospital, Binzhou, 256600, Shandong, China.
- State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Food Nutrition and Safety, Ministry of Education, College of Food Science and Bioengineering, Tianjin University of Science and Technology, Tianjin, C…
- College of Biological and Pharmaceutical Engineering, Shandong University of Aeronautics, Binzhou, 256600, Shandong, China. linyanjun@sdua.edu.cn.
Förderung
- Binzhou Municipal Medical and Health Science and Technology Project
- Natural Science Foundation of Shandong Province
Zitieren
APA
Su, Z., Han, L., Song, F., Wang, Y., & Lin, Y. (2026). β-defensin 130 Counteracts ETEC-K88 Infection in Mice: Mechanistic Insights from Gut Microbiome and LC-MS-Based Metabolomic Correlation Analysis. Current Microbiology. https://doi.org/10.1007/s00284-026-05189-2
Vancouver
Su Z, Han L, Song F, Wang Y, Lin Y. β-defensin 130 Counteracts ETEC-K88 Infection in Mice: Mechanistic Insights from Gut Microbiome and LC-MS-Based Metabolomic Correlation Analysis. Current Microbiology. 2026. doi:10.1007/s00284-026-05189-2
BibTeX
@article{Su2026,
author = {Su, Zhiwei and Han, Lili and Song, Fengfeng and Wang, Yijie and Lin, Yanjun},
title = {β-defensin 130 Counteracts ETEC-K88 Infection in Mice: Mechanistic Insights from Gut Microbiome and LC-MS-Based Metabolomic Correlation Analysis},
journal = {Current Microbiology},
year = {2026},
doi = {10.1007/s00284-026-05189-2}
}
EUVIMED